INS and metabolic syndrome: There is much evidence to demonstrate that type 1 diabetes patients, like patients with type 2 diabetes, are at a greater risk than the general population of being overweight or obese, of developing metabolic syndrome (MetS) and of developing resistance to injected insulin [20,21,22,23,24,25,26].